The All India Institute of Medical Sciences has initiated human trials of Covaxin, India’s first indigenous COVID-19 vaccine on healthy volunteers.
AIIMS in Delhi on July 24, 2020, conducted the first trial of Covaxin. They administered the vaccine to a 30-year-old man who had volunteered for the examination. Dr. Sanjay Rai, Professor at the Center for Community Medicine at AIIMS, said that after injecting the drug, they monitored the person for two hours. No immediate side effects have been observed. After showing no signs of side-effects, they sent him back home. AIIMS Director Dr. Randeep Guleria had said the trial would be carried in three phases, for which 1,125 samples were obtained. Bharat Biotech’s Covaxin at the AIIMS, Delhi, is one of the twelve sites to test the vaccine.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.